Ault, A. US Advisory Panel Urges Government to Subsidise Vaccine Costs. Recommendations Would Increase Vaccination Rates and Stimulate Research and Development. Lancet. 362 (9383): 539; August 16, 2003. Bager, P.; Rostgaard, K.; Nielsen, N. M.; Melbye, M.; Westergaard, T. Age at Bacille CalmetteGuerin Vaccination and Risk of Allergy and Asthma. Clin Exp Allergy. 33 (11): 15121517; November, 2003. Bager, P.; Westergaard, T.; Rostgaard, K.; Nielsen, N. M.; Melbye, M.; Aaby, P. Smallpox Vaccination and Risk of Allergy and Asthma. J Allergy Clin.Immunol. 111 (6): 12271231; June 2003. Baize, S.; Deubel, V. [Accelerated Vaccination for Ebola Hemorrhagic Fever]. Med Sci (Paris). 19 (12): 11831184; December, 2003. Baleta, A. Sri Lanka Opens VaccineSafety Centre. Lancet. 362 (9377): 49; July 5, 2003. Balinska, M. A. Vaccination in Tomorrow's Society. Lancet Infect.Dis. 3 (7): 443447; July, 2003. Baltimore, R. S. and Jenson, H. B. Editorial Review: New Recommendations for Influenza Vaccination for Children and Pregnant Women Curr.Opin.Pediatr. 2003, 15 (1): 7476. Banz, K., Wagenpfeil, S., Neiss, A., Goertz, A., Staginnus, U., Vollmar, J., and Wutzler, P. The CostEffectiveness of Routine Childhood Varicella Vaccination in Germany Vaccine 372003, 21 (1112): 12561267. Barbero, Gonzalez A.; Alvarez de Toledo, Saavedra F.; Esteban, Fernandez J.; PastorSanchez, R.; Gil, de Miguel; Rodriguez Barrios, J. M.; Garcia, Cebrian F.; Capdevilla, Prim C. [Management of Vaccinations and Prophylaxis of International Travellers From Community Pharmacy (VINTAF Study)]. Aten.Primaria. 32 (5): 276281; September 30, 2003. Bartlett, J., Borio, L., Radonovich, L., Mair, J. S., O'Toole, T., Mair, M., Halsey, N., Grow, R., and Inglesby, T. V. Smallpox Vaccination in 2003: Key Information for Clinicians. Clin.Infect.Dis. 412003, 36 (7): 883902. Bauch, C. T.; Galvani, A. P.; Earn, D. J. Group Interest Versus SelfInterest in Smallpox Vaccination Policy. Proc Natl Acad Sci U S A. 100(18): 10564 10567, September 2, 2003. Baumhackl, U., Franta, C., Retzl, J., Salomonowitz, E., and Eder, G. A Controlled Trial of TickBorne Encephalitis Vaccination in Patients With Multiple Sclerosis. Vaccine 412003, 21 (S1): S56S61. Bearman, G.; Fuentes, L.; Van Vorenkamp, J. L.; Drusin, L. M. Vaccination Without Documentation: Influenza Immunization Among Medical Residents at a TertiaryCare Medical Center. Infect Control Hosp.Epidemiol. 24 (8): 626628; August 2003. Begue, P. [Vaccination in France]. Arch Pediatr. 10 (6): 571578; June, 2003. Bellaby, P. Communication and Miscommunication of Risk: Understanding UK Parents' Attitudes to Combined MMR Vaccination. BMJ. 327 (7417): 725 728; September 27, 2003. Benjamin, G. C. Smallpox Vaccination Policy: Part IIPreparedness Begins. Physician Exec. 2003, 29 (2): 6163. Bennett, M. E.; Ledell, K. Current InfectionControl Issues for Smallpox Disease and Vaccinia Vaccine. J Lab Clin Med. 142 (4): 239245; October, 2003. Beran, J.; Moravik, J. Effectiveness of Vaccination Against Influenza in SkodaAuto Company Employees During the Influenza Season 20002001. Cent.Eur.J.Public Health. 11 (4): 209212; December, 2003. Berg, H. F., Van Gendt, J., Rimmelzwaan, G. F., Peeters, M. F., and Van Keulen, P. Nosocomial Influenza Infection Among PostInfluenzaVaccinated Patients With Severe Pulmonary Diseases. J Infect. 2003, 46 (2): 129132. Bernsen, R. M.; de Jongste, J. C.; van der Wouden, J. C. Lower Risk of Atopic Disorders in Whole Cell PertussisVaccinated Children. Eur Respir J. 22 (6): 962964; December, 2003. Bernstein, D. I., Yan, L., Treanor, J., Mendelman, P. M., and Belshe, R. Effect of Yearly Vaccinations With Live, Attenuated, ColdAdapted, Trivalent, Intranasal Influenza Vaccines on Antibody Responses in Children Pediatr.Infect.Dis.J 2003, 22 (1): 2834. Beutels, P. and Gay, N. J. Economic Evaluation of Options for Measles Vaccination Strategy in a Hypothetical Western European Country. Epidemiol Infect. 2003, 130 (2): 273283. Bidat, E.; Rance, F.; Gaudelus, J. [Vaccination in Children With Egg Allergy]. Arch.Pediatr. 10 (3): 251253; March 2003. Billittier, A. J.; Lupiani, P.; Masterson, G.; Masterson, T.; Zak, C. Electronic Patient Registration and Tracking at Mass Vaccination Clinics: a Clinical Study. J.Public Health Manag.Pract. 9 (5): 401410; September, 2003. Birmingham, M. E.; Lewis, R. F.; Perea, W.; Nelson, C. B.; Kabore, A.; Tarantola, D. Routine Vaccination With Polysaccharide Meningococcal Vaccines Is an Ineffective and Possibly Harmful Strategy. Bull.World Health Organ. 81 (10): 751752; 2003. Bishaia, D., Koenig, M., and Khan, M. A. Measles Vaccination Improves the Equity of Health Outcomes: Evidence From Bangladesh. Health Econ. 2003, 12 (5): 415419. Blakeney, B. Statement of Barbara Blakeney, MS, APRN, BC, ANP President, American Nurses Association. Regarding National Network for Immunization Information (NNii) Smallpox Vaccination Survey FindingsJanuary 22, 2003. Ala Nurse 2003, 30 (1): 12. Bodkin, C.; Klopper, H. C. SelfCare Practices and the Need for Influenza Vaccination in Healthy Individuals. Int.J.Nurs.Pract. 9 (6): 382388; December, 2003. Bohlke, K.; Galil, K.; Jackson, L. A.; Schmid, D. S.; Starkovich, P.; Loparev, V. N.; Seward, J. F. Postpartum Varicella Vaccination: Is the Vaccine Virus Excreted in Breast Milk? Obstet Gynecol. 102 (5 Pt 1): 970977; November, 2003. BonillaGuerrero, R.; Poland, G. A. Smallpox Vaccines: Current and Future. J Lab Clin Med. 142 (4): 252257; October, 2003. Booss, J. and Davis, L. E. Smallpox and Smallpox Vaccination: Neurological Implications. Neurology 4222003, 60 (8): 12411245. Boran, C.; Coban, Y. K.; Sasmaz, S.; Parmaksiz, G. Huge Keloid Formation After BCG Vaccination. Pediatr Dermatol. 20 (5): 460; September, 2003. Borner, N. Tolerability of Multiple Vaccinations in Travel Medicine. J Travel.Med. 2003, 10 (2): 112116. Bos, J. M.; Rumke, H.; Welte, R.; Postma, M. J. Epidemiologic Impact and CostEffectiveness of Universal Infant Vaccination With a 7Valent Conjugated Pneumococcal Vaccine in the Netherlands. Clin Ther. 25 (10): 26142630; October, 2003. Bothamley, G. H.; Cooper, E.; Shingadia, D.; Mellanby, A. Tuberculin Testing Before BCG Vaccination. BMJ. 327 (7409): 243244; August 2, 2003. Bourdet, S. V.; Kelley, M.; Rublein, J.; Williams, D. M. Effect of a PharmacistManaged Program of Pneumococcal and Influenza Immunization on Vaccination Rates Among Adult Inpatients. Am J Health Syst Pharm. 60 (17): 17671771; September 1, 2003. Bray, M. and Wright, M. E. Progressive Vaccinia. Clin.Infect.Dis. 3152003, 36 (6): 766774. Bray, M. Pathogenesis and Potential Antiviral Therapy of Complications of Smallpox Vaccination. Antiviral Res. 2003, 58 (2): 101114. Breen, D. Pneumococcal Vaccination Programme in Over 65s and atRisk Groups: the Dumfries and Galloway Experience. Commun.Dis.Public Health. 6 (3): 228230; September, 2003. Bridges, C. B., Harper, S. A., Fukuda, K., Uyeki, T. M., Cox, N. J., and Singleton, J. A. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 4252003, 52 (RR8): 134. Bridges, M. J.; Coady, D.; Kelly, C. A.; Hamilton, J.; Heycock, C. Factors Influencing Uptake of Influenza Vaccination in Patients With Rheumatoid Arthritis. Ann.Rheum.Dis. 62 (7): 685; July, 2003. Bridges, M. J.; Coady, D.; Kelly, C. A.; Hamilton, J.; Heycock, C. Factors Influencing Uptake of Influenza Vaccination in Patients With Rheumatoid Arthritis. Ann.Rheum.Dis. 62 (7): 685; July 2003. Brinkman, D. M.; Jolvan der Zijde, C. M.; ten Dam, M. M.; Vossen, J. M.; Osterhaus, A. D.; Kroon, F. P.; van Tol, M. J. Vaccination With Rabies to Study the Humoral and Cellular Immune Response to a TCell Dependent Neoantigen in Man. J.Clin.Immunol. 23 (6): 528538; November, 2003. Brisson, M. and Edmunds, W. J. Economic Evaluation of Vaccination Programs: the Impact of HerdImmunity Med.Decis.Making 2003, 23 (1): 7682. Brisson, M., Edmunds, W. J., and Gay, N. J. Varicella Vaccination: Impact of Vaccine Efficacy on the Epidemiology of VZV. J Med.Virol. 2003, 70 Suppl 1:S317. (): S31S37. Brisson, M.; Edmunds, W. J. Varicella Vaccination in England and Wales: CostUtility Analysis. Arch Dis Child. 88 (10): 862869; October, 2003.
Brodkin, H. Economic Analysis of Influenza Vaccination and Treatment. Ann.Intern.Med. 412003, 138 (7): 607609. Brotherton, J. M., Delpech, V. C., Gilbert, G. L., Hatzi, S., Paraskevopoulos, P. D., and McAnulty, J. M. A Large Outbreak of Influenza A and B on a Cruise Ship Causing Widespread Morbidity. Epidemiol Infect. 2003, 130 (2): 263271. Brotherton, J.; McAnulty, J. A Pertussis Epidemic in NSW: How Epidemiology Reflects Vaccination Policy. N.S W.Public Health Bull. 14 (45): 7781; April 2003. Brydak, L. B.; Machala, M.; Mysliwska, J.; Mysliwski, A.; Trzonkowski, P. Immune Response to Influenza Vaccination in an Elderly Population. J Clin.Immunol. 23 (3): 214222; May 2003. Buchwald, U. K. and Pirofski, L. Immune Therapy for Infectious Diseases at the Dawn of the 21(St) Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers. Curr.Pharm.Des 2003, 9 (12): 945968. Buchwald, U. K. and Pirofski, L. Immune Therapy for Infectious Diseases at the Dawn of the 21(St) Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers. Curr.Pharm.Des 2003, 9 (12): 945968. Bueving, H. J.; Bernsen, R. M.; de Jongste, J. C.; SuijlekomSmit, L. W.; Rimmelzwaan, G. F.; Osterhaus, A. D.; RuttenVan Molken, M. P.; Thomas, S.; van der Wouden, J. C. Influenza Vaccination in Asthmatic Children: Randomised DoubleBlind PlaceboControlled Trial. Am J Respir Crit Care Med. December 4, 2003. Bugiani, M., Borraccino, A., Migliore, E., Carosso, A., Piccioni, P., Cavallero, M., Caria, E., Salamina, G., and Arossa, W. Tuberculin Reactivity in Adult BCGVaccinated Subjects: a CrossSectional Study. Int J Tuberc Lung Dis. 2003, 7 (4): 320326. Bugri, S. Meningococcal Meningitis Vaccination: More Information Needed. Bull.World Health Organ. 81 (10): 755; 2003. Burns, V. E., Carroll, D., Ring, C., and Drayson, M. Antibody Response to Vaccination and Psychosocial Stress in Humans: Relationships and Mechanisms. Vaccine 622003, 21 (1920): 25232534. Burns, V. E.; Carroll, D.; Drayson, M.; Whitham, M.; Ring, C. Life Events, Perceived Stress and Antibody Response to Influenza Vaccination in Young, Healthy Adults. J Psychosom.Res. 55 (6): 569572; December, 2003. Butler, D. WHO Prepares for Final Push to Rid the World of Polio. Nature. 424 (6949): 604; August 7, 2003. Campins, Marti M., Casal, Lombos J., Tarrago, Asensio D., Rodrigo Anoro Mf, M. J., Allepuz, Palau A., and C7llis, Bracons L. [Persistence of Antibodies Three Years After Vaccination With the 23Valent Pneumococcal Vaccine]. An Pediatr.(Barc.) 2003, 58 (2): 184187. Campins, Marti M.; Alemany, Vilches L. [Influenza Vaccination: Only Advantages?]. Med Clin (Barc.). 121 (18): 703704; November 22, 2003. Cardenosa, N.; Dominguez, A.; Martinez, A.; Alvarez, J.; Panella, H.; Godoy, P.; Minguell, S.; Camps, N.; Vazquez, J. A. Meningococcal Disease in Catalonia 1 Year After Mass Vaccination Campaign With Meningococcal Group C Polysaccharide Vaccine. Infection. 31 (6): 392397; December, 2003. Cavdar, C., Sayan, M., Sifil, A., Artuk, C., Yilmaz, N., Bahar, H., and Camsari, T. The Comparison of Antibody Response to Influenza Vaccination in Continuous Ambulatory Peritoneal Dialysis, Hemodialysis and Renal Transplantation Patients. Scand J Urol Nephrol. 2003, 37 (1): 7176. Chapman, R. S., Cross, K. W., and Fleming, D. M. The Incidence of Shingles and Its Implications for Vaccination Policy. Vaccine 622003, 21 (1920): 25412547. Charatan, F. US Panel Advises Caution Over Smallpox Vaccination. BMJ. 327 (7412): 414; August 23, 2003. Cherian, T., Varkki, S., Raghupathy, P., Ratnam, S., and Chandra, R. K. Effect of Vitamin A Supplementation on the Immune Response to Measles Vaccination. Vaccine 622003, 21 (1920): 24182420. Cherry, J. D. Risks to Children of Health Care Personnel Receiving Smallpox Vaccination. Pediatr.Infect.Dis J. 22 (6): 574575; June 2003. Chowdhury, A. M.; Bhuiya, A.; Mahmud, S.; Abdus Salam, A. K.; Karim, F. Immunization Divide: Who Do Get Vaccinated in Bangladesh? J.Health Popul.Nutr. 21 (3): 193204; September, 2003. Chu, N. R. Therapeutic Vaccination for the Treatment of Mucosotropic Human PapillomavirusAssociated Disease. Expert.Opin.Biol.Ther. 3 (3): 477486; June 2003. Claes, C. and Graf Von Der Schulenburg, JM Cost Effectiveness of Pneumococcal Vaccination for Infants and Children With the Conjugate Vaccine PnC7 in Germany. Pharmacoeconomics. 2003, 21 (8): 587600. Classen, J. B.; Classen, D. C. Clustering of Cases of Type 1 Diabetes Mellitus Occurring 24 Years After Vaccination Is Consistent With Clustering After Infections and Progression to Type 1 Diabetes Mellitus in Autoantibody Positive Individuals. J Pediatr.Endocrinol.Metab. 16 (4): 495508; April 2003. Clements, C. Mass Psychogenic Illness After Vaccination. Drug Saf. 26 (9): 599604; 2003. Cochran, C. E., Smith, D. R., Reid, G., Morrow, H., and Ramirez, J. Protecting Texas Children: EvidenceBased Recommendations for Improving Childhood Vaccination Rates. Tex.Med. 2003, 99 (3): 5260. Cohen, R. [Antipneumococcal Vaccines in SickleCell Anemia and Asplenia]. Presse Med. 32 (28 Suppl): S12S14; September 6, 2003. Colino, J. and Snapper, C. M. Dendritic Cells, New Tools for Vaccination. Microbes.Infect. 2003, 5 (4): 311319. Conti, R. Smallpox Vaccinations: the Risks and the Benefits. Issue.Brief.(Commonw.Fund.) 2003, 620): 19. Cooper, P. J.; Chico, M. E.; Gaus, D.; Griffin, G. E. Relationship Between Bacille CalmetteGuerin Vaccination, Mantoux Test Positivity, and Geohelminth Infection. Trans.R.Soc.Trop.Med.Hyg. 97 (4): 473476; July, 2003. Cotter, B., Bremer, V., Stroh, G., Msambichaka, K., Mabuzane, E., Munyoro, M., Shirehwa, F., Biellik, R., and Birmingham, M. Assessment of Neonatal Tetanus Elimination in an African Setting by Lot Quality Assurance Cluster Sampling (LQACS). Epidemiol Infect. 2003, 130 (2): 221226. Coudeville, L. Measles Dynamics and Vaccination DiffusionA Model and an Application. Eur J Health Econ; 4 (4): 319326; December, 2003. Crabb, C. Developing Countries Overstate Vaccination Coverage. Bull.World Health Organ. 81 (11): 851; 2003. Crotty, S.; Felgner, P.; Davies, H.; Glidewell, J.; Villarreal, L.; Ahmed, R. Cutting Edge: LongTerm B Cell Memory in Humans After Smallpox Vaccination. J Immunol. 171 (10): 49694973; November 15, 2003. Crump, S. C. and Oxley, M. Society of Homeopaths Does Not Advise Against Vaccination BMJ 1182003, 326 (7381): 164. Culley, F. J.; Olszewska, W. Physical Trauma of Vaccination Acts As a WakeUp Call to Dangers in the Skin. Immunology. 110 (3): 291292; November, 2003. Daly, A. D.; Nxumalo, M. P.; Biellik, R. J. Missed Opportunities for Vaccination in Health Facilities in Swaziland. S Afr Med J. 93 (8): 606610; August, 2003. D'Amelio, R.; Biselli, R.; Natalicchio, S.; Lista, F.; Peragallo, M. S. Vaccination Programmes in the Italian Military. Vaccine. 21 (2526): 35303533; September 8, 2003. Dannetun, E.; Tegnell, A.; Normann, B.; Garpenholt, O.; Giesecke, J. Influenza Vaccine Coverage and Reasons for NonVaccination in a Sample of People Above 65 Years of Age, in Sweden, 19982000. Scand.J Infect Dis. 35 (67): 389393; 2003. Darling, R. G.; Waeckerle, J. F.; Grabenstein, C. O.; Koenig, K. L. Removing Health Care Workers From Clinical Duties After Smallpox Vaccination: Is It Really Necessary? Ann Emerg.Med. 42 (5): 685688; November, 2003. Das, J. and Das, S. Trust, Learning, and Vaccination: a Case Study of a North Indian Village. Soc Sci Med. 2003, 57 (1): 97112. Das, J.; Das, S. Trust, Learning, and Vaccination: A Case Study of a North Indian Village. Soc.Sci Med. 57 (1): 97112; July, 2003. Dasgupta, S.; Bhinge, A.; Chandran, V.; Sewlikar, S.; Nimbkar, A.; Datta, D. Role of LLysine HCl in Immunopotentiation Towards Development of Suitable Tuberculosis Vaccination. Vaccine. 21 (32): 47224727; December 1, 2003. De Serres, G., Boulianne, N., Duval, B., Rochette, L., Grenier, J. L., Roussel, R., Donaldson, D., Tremblay, M., Toth, E., Menard, S., Landry, M., and Robert, Y. OculoRespiratory Syndrome Following Influenza Vaccination: Evidence for Occurrence With More Than One Influenza Vaccine. Vaccine 622003, 21 (1920): 23462353. De Serres, G., Grenier, J. L., Toth, E., Menard, S., Roussel, R., Tremblay, M., Fradet, M. D., Landry, M., Robert, Y., and Skowronski, D. M. The Clinical Spectrum of the OculoRespiratory Syndrome After Influenza Vaccination. Vaccine 622003, 21 (1920): 23542361.
- Page 1 and 2:
BIBLIOGRAFIA SUI DANNI DA VACCINI A
- Page 3 and 4:
Alter HJ, Scanlon RT, Schechter GP.
- Page 5 and 6:
Cherry, JD, et al. A Clinical and S
- Page 7 and 8:
Kazarian EL, Gager WE. Optic neurit
- Page 9 and 10: Coplan J. Seizures following immuni
- Page 11 and 12: Ipp MM, Gold R, Greenberg S, Goldba
- Page 13 and 14: Int J Ped Oto, Feb 1998, 43(1):73
- Page 15 and 16: Mashikian MV, Stollerman GH. Vaccin
- Page 17 and 18: Wu T, Wang SL, Xiang YZ. Study on t
- Page 19 and 20: Prevots DR, Ciofi degli Atti ML, Sa
- Page 21 and 22: Del Giudice G, Pizza M, Rappuoli R.
- Page 23 and 24: Huber S, Kappos L, Fuhr P, Wetzel S
- Page 25 and 26: Ngui SL, Hallet R, Teo CG. Natural
- Page 27 and 28: Thomson J, Hilditch A, Pirkis J, Du
- Page 29 and 30: Belloni C, Pistorio A, Tinelli C, K
- Page 31 and 32: DanielRibeiro CT. Is there a role
- Page 33 and 34: Gallup, R. The MMR question [letter
- Page 35 and 36: Hull BP, McIntyre PB. A reevaluat
- Page 37 and 38: Lieu TA, Ray GT, Black SB, Butler J
- Page 39 and 40: Mulholland K. Evaluation of vaccine
- Page 41 and 42: Rudolph, K. M., Parkinson, A. J., R
- Page 43 and 44: Taylor JA, Newman RD. Parental atti
- Page 45 and 46: Bonaccorsi G, Papini D, Bonanni P,
- Page 47 and 48: Hanna, J. N., Young, D. M., Brookes
- Page 49 and 50: Mortimer, E. A. Jr, Ball, R., Ball,
- Page 51 and 52: Taranger, J., Trollfors, B., Bergfo
- Page 53 and 54: Christensen, L. S., Scholler, S., S
- Page 55 and 56: Khanal, P. Nepal's Childhood Mortal
- Page 57 and 58: Poland GA, Jacobson RM, Vierkant RA
- Page 59: Vyse, A. J., Gay, N. J., White, J.
- Page 63 and 64: Freed, G. L., Davis, M. M., and Cla
- Page 65 and 66: Karlsen, T. H.; Sommerfelt, H.; Klo
- Page 67 and 68: NascimentoCarvalho, C. M.; Moreno
- Page 69 and 70: Skegg, D. C. Autism and MeaslesMu
- Page 71 and 72: Wharton, M., Strikas, R. A., Harpaz
- Page 73 and 74: Boyce, T. G.; Weaver, A. L.; St Sau
- Page 75 and 76: D'Heilly, S. J.; Nichol, K. L. Work
- Page 77 and 78: Guy, B.; Chanthavanich, P.; Gimenez
- Page 79 and 80: Koca, R.; Altinyazar, H. C.; Numano
- Page 81 and 82: Modlin, J. F. Poliomyelitis in the
- Page 83 and 84: Roost, H. P.; Gassner, M.; Grize, L
- Page 85 and 86: Vazquez, M.; LaRussa, P. S.; Gersho
- Page 87 and 88: Beaujean, D. J.; Verweij, M. F.; va
- Page 89 and 90: Desjeux, G.; GaloisyGuibal, L.; C
- Page 91 and 92: Gust, D.; Brown, C.; Sheedy, K.; Hi
- Page 93 and 94: Koch, D.; Thompson, L.; Swart, B. L
- Page 95 and 96: Newport, M. J.; Goetghebuer, T.; Ma
- Page 97 and 98: Satcher, D. Adult Immunization Disp
- Page 99 and 100: Timmermans, D. R.; Henneman, L.; Hi
- Page 101 and 102: Aaby, P.; Jensen, H.; Walraven, G.
- Page 103 and 104: Carrat, F.; Lavenu, A.; Cauchemez,
- Page 105 and 106: Emanuel, E. J.; Wertheimer, A. Publ
- Page 107 and 108: Halperin, S. A.; Sweet, L.; Baxenda
- Page 109 and 110: Klote, M. M.; Engler, R. J.; Martin
- Page 111 and 112:
Mitka, M. Age Range Widens for Pert
- Page 113 and 114:
Pool, V.; Iskander, J. Safety of In
- Page 115 and 116:
Skowronski, D. M.; Woolcott, J. C.;
- Page 117 and 118:
Vu, D. M.; Kelly, D.; Heath, P. T.;
- Page 119 and 120:
Approved: New Requirement Allowing
- Page 121 and 122:
Caldwell, S. J.; Hayney, M. S. Prop
- Page 123 and 124:
Dempsey, A. F. Vaccination Against
- Page 125 and 126:
Galvani, A. P.; Reluga, T. C.; Chap
- Page 127 and 128:
Influenza Vaccination Coverage Amon
- Page 129 and 130:
Lawrence, S. J.; Lottenbach, K. R.;
- Page 131 and 132:
Monath, T. P. Yellow Fever As an En
- Page 133 and 134:
Patrick, D. Prevention Strategies:
- Page 135 and 136:
Scheiblhofer, S.; Weiss, R.; Thalha
- Page 137 and 138:
Takada, T.; Yamashita, T.; Sato, M.
- Page 139 and 140:
Winston, C. A.; Mims, A. D.; Leathe
- Page 141 and 142:
Bechtol, Z. Launching a Community
- Page 143 and 144:
Chumakov, K.; Ehrenfeld, E. Vaccine
- Page 145 and 146:
Dylag, A. M.; Shah, S. I. Administr
- Page 147 and 148:
GomezdeLeon, P.; DiazGarcia,
- Page 149 and 150:
Jackson, L. A.; Starkovich, P.; Dun
- Page 151 and 152:
Kusuhara, K.; Ohga, S.; Hoshina, T.
- Page 153 and 154:
Madjid, M. Acute Infections, Vaccin
- Page 155 and 156:
Naghipour, M.; Nakagomi, T.; Nakago
- Page 157 and 158:
Pool, R.; Mushi, A.; Armstrong, Sch
- Page 159 and 160:
Savidan, E.; Chevat, C.; Marsh, G.
- Page 161 and 162:
Strauman, T. J.; Coe, C. L.; McCrud
- Page 163 and 164:
Vien, N. C.; Feroldi, E.; Lang, J.
- Page 165 and 166:
Akmatov, M. K.; Mikolajczyk, R. T.;
- Page 167 and 168:
Braillon, A. A New French Paradox:
- Page 169 and 170:
Daley, M. F.; Curtis, C. R.; Pyrzan
- Page 171 and 172:
Flu Campaign Receives Excellence Aw
- Page 173 and 174:
Holvast, A.; van, Assen S.; de, Haa
- Page 175 and 176:
Kisakye, A.; Makumbi, I.; Nansera,
- Page 177 and 178:
Makidon, P. E.; Nigavekar, S. S.; B
- Page 179 and 180:
Niu, M.; Ball, R. Adverse Events Af
- Page 181 and 182:
Primus, L. Improving Influenza Vacc
- Page 183 and 184:
Schwartz, B.; Orenstein, W. A. Prio
- Page 185 and 186:
Tharmaphornpilas, P.; Yoocharean, P
- Page 187 and 188:
Weiskopf, D.; Weinberger, B.; Grube